Literature DB >> 14987568

The p38 MAP kinase pathway and its biological function.

L New1, J Han.   

Abstract

p38 is a mitogen-activated protein (MAP) kinase with structural and functional characteristics that distinguish it from JNK and ERK MAP kinases. p38 activity is upregulated when cells are exposed to a variety of stimuli including bacterial pathogens, proinflammatory cytokines, certain growth factors, and other forms of environmental stress. By regulating downstream substrates that include protein kinases and transcription factors, p38 participates in transmission, amplification, and diversification of the extracellular signal, initiating several different cellular responses. Studies have revealed that activation of p38 pathway is related to many pathological changes that occur in the course of inflammatory/immunologic and cardiovascular diseases.

Entities:  

Year:  1998        PMID: 14987568     DOI: 10.1016/s1050-1738(98)00012-7

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  36 in total

1.  Differential pharmacological behaviour of p38 inhibitors in regulating the LPS-induced TNF-α production in human and rat whole blood in vitro.

Authors:  Mercè Pont-Giralt; Núria Godessart; Cristina Balagué
Journal:  Inflammation       Date:  2011-04       Impact factor: 4.092

2.  Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.

Authors:  Asuka Ota; Jun Zhang; Peipei Ping; Jiahuai Han; Yibin Wang
Journal:  Circ Res       Date:  2010-03-18       Impact factor: 17.367

3.  Immunostimulatory activity of snake fruit peel extract on murine macrophage-like J774.1 cells.

Authors:  Sri Wijanarti; Agus Budiawan Naro Putra; Kosuke Nishi; Eni Harmayani; Takuya Sugahara
Journal:  Cytotechnology       Date:  2015-10-19       Impact factor: 2.058

4.  p38 MAPK Participates in the Mediation of GLT-1 Up-regulation During the Induction of Brain Ischemic Tolerance by Cerebral Ischemic Preconditioning.

Authors:  Min Zhang; Jian-Xue Gong; Jia-Lei Wang; Meng-Yang Jiang; Li Li; Yu-Yan Hu; Jie Qi; Ling-Yan Zhang; Hang Zhao; Xin Cui; Xiao-Hui Xian; Wen-Bin Li
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

5.  Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors.

Authors:  Tony A Navas; Mani Mohindru; Myka Estes; Jing Ying Ma; Lubomir Sokol; Perry Pahanish; Simrit Parmar; Edwin Haghnazari; Li Zhou; Robert Collins; Irene Kerr; Aaron N Nguyen; Yin Xu; Leonidas C Platanias; Alan A List; Linda S Higgins; Amit Verma
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

6.  Astrocytes express Mxi2, a splice isoform of p38MAPK.

Authors:  Guillermo Bodega; Sergio Ciordia; Isabel Suárez; Luis Andrés López-Fernández; Enrique Vacas; Gonzalo Sánchez-Tejeda; María Amparo Albert; Silvia Juárez; Juan Pablo Albar; Benjamín Fernández
Journal:  J Mol Histol       Date:  2009-12-31       Impact factor: 2.611

7.  The role of p38alpha mitogen-activated protein kinase gene in the HELLP syndrome.

Authors:  Alessandra Corradetti; Franca Saccucci; Monica Emanuelli; Giorgia Vagnoni; Monia Cecati; Davide Sartini; Stefano R Giannubilo; Andrea L Tranquilli
Journal:  Cell Stress Chaperones       Date:  2009-06-30       Impact factor: 3.667

8.  Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation.

Authors:  S Okamoto; D Krainc; K Sherman; S A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

9.  Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest.

Authors:  X Wang; C H McGowan; M Zhao; L He; J S Downey; C Fearns; Y Wang; S Huang; J Han
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

10.  Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.

Authors:  Jinhua Li; Naomi Vittoria Campanale; Rong Jiao Liang; James Antony Deane; John Frederick Bertram; Sharon Denise Ricardo
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.